Dr. Robert A. Wohlman, MD

Dr. Wohlman practices at Logan Health Medical Center in Kalispell, Montana, part of Billings Clinic.

Dr. Wohlman's NPI, 1265412019, was assigned on January 18, 2006. Dr. Wohlman holds Washington license 21426.

Dr. Wohlman's primary practice is Logan Health Medical Center, at 310 Sunnyview Lane, Kalispell, MT 59901 in Flathead County. The practice phone is (406) 752-5111.

Dr. Wohlman's primary practice is Logan Health Medical Center in Kalispell, Montana, part of Billings Clinic. Dr. Wohlman is also affiliated with Asante Rogue Regional Medical Center. The medical group on file is Good Shepherd Medical Group. Dmand AI also links Dr. Wohlman to 3 more hospitals, 9 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wohlman practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Wohlman's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Wohlman's licenses on file in 4 states: Washington, Colorado, Montana and Oregon.

CMS data shows 118 Medicare services from Dr. Wohlman across 5 procedure codes in 2024, for 95 Medicare patients. Medicare paid $8,966 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 95 Medicare patients who saw Dr. Wohlman in 2024. The largest group is 65 to 74, with 42 patients. 74% of them have high blood pressure, and 66% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wohlman's median patient age at 68, with 50% women.

In 2024, Dr. Wohlman wrote 225 Medicare Part D claims for 107 patients. 77% of them were for generic drugs. CMS names the drug for 95 of them, across 3 drugs with 11 or more claims each, at $5,015 in total drug cost. In 2023, CMS named 870 claims across 25 drugs.

Dr. Wohlman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 59 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Wohlman, more than 66% of the clinicians it reports for that procedure.

Dmand AI links Dr. Wohlman to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative, Crohn Disease and Colitis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Wohlman that name 2 trials.

CMS Open Payments shows 439 general payments to Dr. Wohlman from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Phathom Pharmaceuticals, Inc. paid the most, $18,329. It also lists 2 research payments totaling $14,829 from 2021 to 2023, naming 2 clinical trials.